author-photo

Hannah Proetsch-Gugerbauer

California Pacific Medical Center

1

Papers

9

Citations

Citation Trend

Filter By

Papers (1) Sort By

Journal Conference Others

Dinaciclib, a cyclin-dependent kinase inhibitor, suppresses cholangiocarcinoma growth by targeting CDK2/5/9.

2020 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (9)